- call +1-201-465-4211
- email sales@mrinsights.biz
Monoclonal antibody therapeutics is a type of immunotherapy in which monoclonal antibodies are used so that they can bind monospecifically to specific cells and proteins.
Scope of the Report:
This report focuses on the Monoclonal Antibodies in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
This treatment stimulates the immune system of patients to attack the foreign cells which cause the disease. Monoclonal antibodies are produced by using hybridoma technology. In hybridoma technology, the antibodies are obtained by fusion of human spleen cells and human myeloma. The characteristics of monoclonal antibodies which affect their efficacy are antigen specificity, overall structure and the affinity of the antibody for the target antigen or cells.
The worldwide market for Monoclonal Antibodies is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new study.
Market Segment by Manufacturers, this report covers
AbbVie
Roche
Johnson & Johnson
Amgen
Merck
BMS
Eli Lilly
Formation Biologics
Genmab
GlaxoSmithKline
Human Genome Sciences
mmunogen
MedImmune
Novartis
Pfizer
Seattle Genetics
Stemcentrx
Synthon Biopharmaceuticals
Takeda
Teva
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Cancer
Autoimmune Diseases
Infection
Hematological Diseases
Others
Market Segment by Applications, can be divided into
Oncology
Autoimmune and inflammatory diseases
Respiratory diseases
Ophthalmology
There are 15 Chapters to deeply display the global Monoclonal Antibodies market.
Chapter 1, to describe Monoclonal Antibodies Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Monoclonal Antibodies, with sales, revenue, and price of Monoclonal Antibodies, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Monoclonal Antibodies, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Monoclonal Antibodies market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Monoclonal Antibodies sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Monoclonal Antibodies Introduction
1.2 Market Analysis by Type
1.2.1 Cancer
1.2.2 Autoimmune Diseases
1.2.3 Infection
1.2.4 Hematological Diseases
1.2.5 Others
1.3 Market Analysis by Applications
1.3.1 Oncology
1.3.2 Autoimmune and inflammatory diseases
1.3.3 Respiratory diseases
1.3.4 Ophthalmology
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AbbVie
2.1.1 Business Overview
2.1.2 Monoclonal Antibodies Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AbbVie Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Roche
2.2.1 Business Overview
2.2.2 Monoclonal Antibodies Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Roche Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Johnson & Johnson
2.3.1 Business Overview
2.3.2 Monoclonal Antibodies Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Johnson & Johnson Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Amgen
2.4.1 Business Overview
2.4.2 Monoclonal Antibodies Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Amgen Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Merck
2.5.1 Business Overview
2.5.2 Monoclonal Antibodies Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Merck Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 BMS
2.6.1 Business Overview
2.6.2 Monoclonal Antibodies Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 BMS Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Eli Lilly
2.7.1 Business Overview
2.7.2 Monoclonal Antibodies Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Eli Lilly Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Formation Biologics
2.8.1 Business Overview
2.8.2 Monoclonal Antibodies Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Formation Biologics Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Genmab
2.9.1 Business Overview
2.9.2 Monoclonal Antibodies Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Genmab Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 GlaxoSmithKline
2.10.1 Business Overview
2.10.2 Monoclonal Antibodies Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 GlaxoSmithKline Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Human Genome Sciences
2.11.1 Business Overview
2.11.2 Monoclonal Antibodies Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Human Genome Sciences Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 mmunogen
2.12.1 Business Overview
2.12.2 Monoclonal Antibodies Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 mmunogen Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 MedImmune
2.13.1 Business Overview
2.13.2 Monoclonal Antibodies Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 MedImmune Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Novartis
2.14.1 Business Overview
2.14.2 Monoclonal Antibodies Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Novartis Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Pfizer
2.15.1 Business Overview
2.15.2 Monoclonal Antibodies Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Pfizer Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Seattle Genetics
2.16.1 Business Overview
2.16.2 Monoclonal Antibodies Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Seattle Genetics Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 Stemcentrx
2.17.1 Business Overview
2.17.2 Monoclonal Antibodies Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Stemcentrx Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18 Synthon Biopharmaceuticals
2.18.1 Business Overview
2.18.2 Monoclonal Antibodies Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Synthon Biopharmaceuticals Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.19 Takeda
2.19.1 Business Overview
2.19.2 Monoclonal Antibodies Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Takeda Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.20 Teva
2.20.1 Business Overview
2.20.2 Monoclonal Antibodies Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Teva Monoclonal Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Monoclonal Antibodies Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Monoclonal Antibodies Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Monoclonal Antibodies Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Monoclonal Antibodies Manufacturer Market Share in 2017
3.3.2 Top 6 Monoclonal Antibodies Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Monoclonal Antibodies Market Analysis by Regions
4.1 Global Monoclonal Antibodies Sales, Revenue and Market Share by Regions
4.1.1 Global Monoclonal Antibodies Sales and Market Share by Regions (2013-2018)
4.1.2 Global Monoclonal Antibodies Revenue and Market Share by Regions (2013-2018)
4.2 North America Monoclonal Antibodies Sales and Growth Rate (2013-2018)
4.3 Europe Monoclonal Antibodies Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Monoclonal Antibodies Sales and Growth Rate (2013-2018)
4.5 South America Monoclonal Antibodies Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Monoclonal Antibodies Sales and Growth Rate (2013-2018)
5 North America Monoclonal Antibodies by Countries
5.1 North America Monoclonal Antibodies Sales, Revenue and Market Share by Countries
5.1.1 North America Monoclonal Antibodies Sales and Market Share by Countries (2013-2018)
5.1.2 North America Monoclonal Antibodies Revenue and Market Share by Countries (2013-2018)
5.2 United States Monoclonal Antibodies Sales and Growth Rate (2013-2018)
5.3 Canada Monoclonal Antibodies Sales and Growth Rate (2013-2018)
5.4 Mexico Monoclonal Antibodies Sales and Growth Rate (2013-2018)
6 Europe Monoclonal Antibodies by Countries
6.1 Europe Monoclonal Antibodies Sales, Revenue and Market Share by Countries
6.1.1 Europe Monoclonal Antibodies Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Monoclonal Antibodies Revenue and Market Share by Countries (2013-2018)
6.2 Germany Monoclonal Antibodies Sales and Growth Rate (2013-2018)
6.3 UK Monoclonal Antibodies Sales and Growth Rate (2013-2018)
6.4 France Monoclonal Antibodies Sales and Growth Rate (2013-2018)
6.5 Russia Monoclonal Antibodies Sales and Growth Rate (2013-2018)
6.6 Italy Monoclonal Antibodies Sales and Growth Rate (2013-2018)
7 Asia-Pacific Monoclonal Antibodies by Countries
7.1 Asia-Pacific Monoclonal Antibodies Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Monoclonal Antibodies Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Monoclonal Antibodies Revenue and Market Share by Countries (2013-2018)
7.2 China Monoclonal Antibodies Sales and Growth Rate (2013-2018)
7.3 Japan Monoclonal Antibodies Sales and Growth Rate (2013-2018)
7.4 Korea Monoclonal Antibodies Sales and Growth Rate (2013-2018)
7.5 India Monoclonal Antibodies Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Monoclonal Antibodies Sales and Growth Rate (2013-2018)
8 South America Monoclonal Antibodies by Countries
8.1 South America Monoclonal Antibodies Sales, Revenue and Market Share by Countries
8.1.1 South America Monoclonal Antibodies Sales and Market Share by Countries (2013-2018)
8.1.2 South America Monoclonal Antibodies Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Monoclonal Antibodies Sales and Growth Rate (2013-2018)
8.3 Argentina Monoclonal Antibodies Sales and Growth Rate (2013-2018)
8.4 Colombia Monoclonal Antibodies Sales and Growth Rate (2013-2018)
9 Middle East and Africa Monoclonal Antibodies by Countries
9.1 Middle East and Africa Monoclonal Antibodies Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Monoclonal Antibodies Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Monoclonal Antibodies Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Monoclonal Antibodies Sales and Growth Rate (2013-2018)
9.3 UAE Monoclonal Antibodies Sales and Growth Rate (2013-2018)
9.4 Egypt Monoclonal Antibodies Sales and Growth Rate (2013-2018)
9.5 Nigeria Monoclonal Antibodies Sales and Growth Rate (2013-2018)
9.6 South Africa Monoclonal Antibodies Sales and Growth Rate (2013-2018)
10 Global Monoclonal Antibodies Market Segment by Type
10.1 Global Monoclonal Antibodies Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Monoclonal Antibodies Sales and Market Share by Type (2013-2018)
10.1.2 Global Monoclonal Antibodies Revenue and Market Share by Type (2013-2018)
10.2 Cancer Sales Growth and Price
10.2.1 Global Cancer Sales Growth (2013-2018)
10.2.2 Global Cancer Price (2013-2018)
10.3 Autoimmune Diseases Sales Growth and Price
10.3.1 Global Autoimmune Diseases Sales Growth (2013-2018)
10.3.2 Global Autoimmune Diseases Price (2013-2018)
10.4 Infection Sales Growth and Price
10.4.1 Global Infection Sales Growth (2013-2018)
10.4.2 Global Infection Price (2013-2018)
10.5 Hematological Diseases Sales Growth and Price
10.5.1 Global Hematological Diseases Sales Growth (2013-2018)
10.5.2 Global Hematological Diseases Price (2013-2018)
10.6 Others Sales Growth and Price
10.6.1 Global Others Sales Growth (2013-2018)
10.6.2 Global Others Price (2013-2018)
11 Global Monoclonal Antibodies Market Segment by Application
11.1 Global Monoclonal Antibodies Sales Market Share by Application (2013-2018)
11.2 Oncology Sales Growth (2013-2018)
11.3 Autoimmune and inflammatory diseases Sales Growth (2013-2018)
11.4 Respiratory diseases Sales Growth (2013-2018)
11.5 Ophthalmology Sales Growth (2013-2018)
12 Monoclonal Antibodies Market Forecast (2018-2023)
12.1 Global Monoclonal Antibodies Sales, Revenue and Growth Rate (2018-2023)
12.2 Monoclonal Antibodies Market Forecast by Regions (2018-2023)
12.2.1 North America Monoclonal Antibodies Market Forecast (2018-2023)
12.2.2 Europe Monoclonal Antibodies Market Forecast (2018-2023)
12.2.3 Asia-Pacific Monoclonal Antibodies Market Forecast (2018-2023)
12.2.4 South America Monoclonal Antibodies Market Forecast (2018-2023)
12.2.5 Middle East and Africa Monoclonal Antibodies Market Forecast (2018-2023)
12.3 Monoclonal Antibodies Market Forecast by Type (2018-2023)
12.3.1 Global Monoclonal Antibodies Sales Forecast by Type (2018-2023)
12.3.2 Global Monoclonal Antibodies Market Share Forecast by Type (2018-2023)
12.4 Monoclonal Antibodies Market Forecast by Application (2018-2023)
12.4.1 Global Monoclonal Antibodies Sales Forecast by Application (2018-2023)
12.4.2 Global Monoclonal Antibodies Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Monoclonal Antibodies Picture
Table Product Specifications of Monoclonal Antibodies
Figure Global Sales Market Share of Monoclonal Antibodies by Types in 2017
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
